Categories:
Nonclinical, Technology and General Science
Microphysiological Systems / Complex Cell Cultures / 3Rs
Management / Business Development
------------------------------------------------------------
Nonclinical Sciences & Technology
April 22 (nonclinical)
Selecting disease-relevant models to derisk drug discovery
Explore how advanced in vitro and in vivo model systems combined with high-throughput CRISPR screening improve translational confidence.
April 23 (Lab Animal)
Managing Aquatic Colonies: Navigating Different Waters
Charles River Labratories -Sponsor
- Address challenges and establish best practices for setting up and maintaining aquatics programs
- Identify environmental factors and pathogens that could affect animal welfare
- Develop and implement an effective health monitoring program
April 28 (nonclinical)
Virtual Control Groups, Actually: What SEND Makes Possible (and What It Doesn’t)
One emerging application is the use of virtual control groups (VCGs), which leverage historical control data to reduce or replace the use of concurrent control animals in toxicology studies.
May 19-20 (Nonclinical)
Pushing Boundaries in Emerging Infectious Disease Research
In this symposium, scientists will highlight innovative approaches for studying pathogens, monitoring infections, and mitigating infectious threats.
April 28
Guide to Using Cre-lox Technology to Generate Tissue-Specific Modifications
- Select appropriate combinations of Cre drivers and loxP-flanked alleles for tissue-specific effects
- Determine breeding strategies to generate knockouts, disease models, or to visualize anatomical structures
- Avoid common pitfalls in generating conditional and inducible models
April 29
Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies: Small Molecules, Peptides, Nucleotides, and other modalities
Sponsored by PBSS
https://www.pbss.org/eventDetails/1017
This event will provide valuable insights for scientists working in DMPK, bioanalysis, and translational research, offering practical perspectives on how evolving analytical technologies are being applied to support drug discovery and development in a rapidly changing therapeutic landscape.
May 6
Accelerating ADC discovery through strategically integrated chemistry, biology, and DMPK
https://register.gotowebinar.com/register/1280099170269548885?source=BioDuro+eMail
- Strategies to optimize conjugation, linkers, and payloads across diverse ADCs
- Insights into ADC biological activity and mechanism-of-action
- Unique workflows for ADME characterization of ADCs and payloads
- Practical insights and case studies from integrated ADC discovery, including Photo-ADC
May 19
Beyond Exposure: Integrating PK/PD for Translational Predictive Power Mechanistic Modeling: Moving beyond descriptive data to build predictive exposure–response models.
- Strategic Biomarker Integration: Selecting and validating the right markers to confirm target engagement.
- Dose Optimization: Pinpointing the therapeutic window for NCEs, large molecules, and ADCs.
- Cross-Modality Insights: Navigating the unique PK/PD challenges of diverse therapeutic platforms.
- Risk Mitigation: Solidifying First-in-Human (FIH) projections and narrowing the “translational gap.”
- Translational Confidence: Hard-coding predictive power into candidate selection to streamline regulatory transitions.
May 27&28
Advancing the drug discovery and development pipeline
Increasing biological complexity, data integration challenges, and evolving regulatory expectations are influencing how researchers identify targets, optimize candidates, and design clinical studies. This two-day symposium will bring together leading experts discussing emerging strategies, technologies, and collaborations that are transforming drug discovery and development across the pharmaceutical industry.
June 3
Endpoints at #ASCO26
We're assembling a panel of oncology insiders to break down the readouts to watch and where the field is actually headed over the next year.
------------------------------------------------------------
Novel Approach Methodologies / Microphysiological Systems
April 22
From Injury to Repair: Advanced 3D Models to Study Regeneration, Inflammation, and Immune Responses
Three-dimensional (3D) in vitro models represent advanced tools for studying tissue physiology, disease mechanisms, and therapeutic interventions. In this work, we employed both static and dynamic 3D culture systems to investigate tissue injury and regenerative or immunological responses
May 5
Organs-on-Chips: Tech Progress & Regulatory Tailwinds
https://event.on24.com/wcc/r/5299642/F88202528C36391A469DCA6571584E5E?partnerref=email-subs-rb-041426&mkt_tok=MDMxLVlJWS01MjkAAAGhLC3yy53VbQ3JYyRFp85FQOBprLBASzViLwoqhLUs80ulx7sVBAuCg9XWKfbTG2YByq4URt_jaw26gIzV3G0LLaZeI3Zw0AxuoShy3V4
Organ-on-chip systems are helping teams generate data earlier across efficacy, toxicity, and mechanism.
- Improve early-stage decision-making
- Generate better tox and PK/PD insights
- De-risk newer, more complex modalities
May 13
Developing Solutions for Organoid Challenges
- How to overcome tissue structure heterogeneity in organoid generation
- How the unique mechanisms used by mammals, birds, and reptiles to build lung epithelium inspire strategies for building organoids
- How micropatterned human pluripotent stem cell-derived gastruloids enable in vitro modeling of early-stage cardiac and hepatic vascularization
------------------------------------------------------------
Business Development
April 28-29 (BD)
From Bench to Start-up
Many academic researchers generate exciting discoveries in the laboratory, but translating those insights into real-world applications often requires taking a bold step into industry. To bring their vision to life, scientists establishing biotechnology startups must navigate a journey that blends rigorous research with strategic planning, team building, and funding. In this symposium, learn how scientists turned their discoveries into startup ventures.
April 23 (BD)
How to Lead a Biopharma Lab: Discovery to Delivery
- Leadership approaches that keep biopharma research aligned with clinical and business objectives
- Methods for managing cross-functional teams working on high-stakes projects
- Techniques to balance speed, compliance, and quality in drug development workflows
- Insights on fostering innovation while meeting tight timelines and regulatory expectations
May 8
Highlights of 2025 FDA Drug Approvals
Sponsored by PBSS
https://us02web.zoom.us/webinar/register/6417758552795/WN__s4ji1S4TeOUGpOaOdrYig#/registration
, the speakers will summarize the 2025 cohort of new drugs approved by the FDA. Statistics on the overall cohort will be discussed, followed by a short summary of key features of approved drugs. The speakers will highlight case studies with interesting discovery or development stories.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------
Create Your Own Website With Webador